Search

everythinglearnresearchcommunity

for

Search:↓

The estrogen receptor pathway controls hair growth cycles and affects skin cell growth.

The new method showed that endometriotic tissue has lower estrogen receptor levels but similar progesterone levels compared to normal endometrium, with both following a similar cycle.

Estrogen and progesterone don't directly affect hair growth in androgenic alopecia and alopecia areata.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

Estrogen receptors may not affect mouse hair growth as previously thought, and oxybenzone in sunscreen is stable in sunlight.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Men have worse COVID-19 outcomes than women due to genetic and hormonal differences.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Tamoxifen can cause total hair loss but its benefits outweigh this side effect.

Coumarin derivatives show promise as anti-estrogenic agents for treating breast cancer, with some in clinical trials.

17β-estradiol may help hair growth by increasing cannabinoid receptor type 1.

The vitamin D receptor is involved in multiple body functions beyond calcium regulation, including immune response and rapid reactions not related to gene activity.

We need better ways to test and understand SARMs to make safer and more effective treatments.

The patient's long-term hair loss was caused by leukemia treatments and low estrogen levels, worsened by her genetic tendency for hair loss.

Estrogen replacement can improve skin health in menopausal women but doesn't reverse sun damage or prevent hair loss.

Estrogen loss during menopause worsens skin health, but hormone replacement therapy may improve it, though more research is needed.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

Chromosomal differences affect how muscle cells respond to testosterone.

Certain genes and X chromosome patterns may significantly contribute to the development of hair loss.

A transwoman developed a brain tumor after nine years of hormone therapy, suggesting a possible link between the treatment and tumor development.

Estradiol-rich plasma can increase hair density faster and more effectively in male pattern baldness treatment than regular plasma.

The conclusion is that proper signaling is crucial for hair growth and development, and errors can lead to cancer or hair loss.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Male genital development is driven by androgen signaling and understanding it could help address congenital anomalies.

Some breast cancer patients on hormonal therapy may develop male or female pattern hair loss, which can sometimes be improved with topical treatments.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Medications for PCOS don't seem to raise heart disease risk.

Hair growth supplements do not reduce the effectiveness of the breast cancer treatment tamoxifen.

Exemestane may protect bones by stimulating osteoblast growth through androgen-related pathways.